Results 49,301-49,320 of 49,836 for speaker:Stephen Donnelly
- Written Answers — Department of Health: Dental Services (5 Nov 2024)
Stephen Donnelly: There are challenges in the provision of oral healthcare services, including orthodontics, and patients are waiting longer than they should have to, to access care. Therefore, in addition to the over €200m that the Government invests in public oral healthcare services annually, an additional €17m in one-off funding has been invested since 2019/2020 to address orthodontics...
- Written Answers — Department of Health: Ambulance Service (5 Nov 2024)
Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.
- Written Answers — Department of Health: Ambulance Service (5 Nov 2024)
Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive (HSE) to respond to the Deputy directly, as soon as possible.
- Written Answers — Department of Health: Hospital Waiting Lists (5 Nov 2024)
Stephen Donnelly: In relation to the particular query raised, as this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.
- Written Answers — Department of Health: Hospital Waiting Lists (5 Nov 2024)
Stephen Donnelly: It is acknowledged that many patients are still waiting too long for hospital appointments and treatments. I am conscious of the burden this places on patients and their families. To address the issue, I adopted a multi-annual approach through a series of Waiting List Action Plans. Commencing in late 2021, these plans encompass short-term actions to increase capacity and activity in the...
- Written Answers — Department of Health: Hospital Waiting Lists (5 Nov 2024)
Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.
- Written Answers — Department of Health: Vaccination Programme (5 Nov 2024)
Stephen Donnelly: The Government recently provided approval for an infant Respiratory Syncytial Virus (RSV) Immunisation Pathfinder Programme which will run between September 2024 and February 2025. All newborn infants born during the programme will be offered immunisation against RSV after birth on site in Irish maternity hospitals. This immunisation will protect newborn infants when they are most...
- Written Answers — Department of Health: Vaccination Programme (5 Nov 2024)
Stephen Donnelly: Shingles vaccination is not currently provided as part of the national immunisation programme but it is open to any individual who is aged 50 years and older and who wishes to receive the vaccine to consult with their GP or pharmacist. The shingles vaccine is not available through the medical card or drug payment schemes. The ages at which vaccines are recommended in the national...
- Written Answers — Department of Health: Civil Service (5 Nov 2024)
Stephen Donnelly: The Minister is satisfied that Circular 4/2013 is being properly implemented in the Department of Health and has no concerns that Civil Servants in his Department are having career breaks extended unnecessarily where the Department has appropriate vacancies to fill.
- Written Answers — Department of Health: Health Services Staff (5 Nov 2024)
Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.
- Written Answers — Department of Health: Health Services Waiting Lists (5 Nov 2024)
Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.
- Written Answers — Department of Health: Health Services Staff (5 Nov 2024)
Stephen Donnelly: As this is a service matter, it has been referred to the Health Service Executive for attention and direct reply to the Deputy.
- Written Answers — Department of Health: Health Services Waiting Lists (5 Nov 2024)
Stephen Donnelly: As this is a service matter, it has been referred to the Health Service Executive for attention and direct reply to the Deputy.
- Written Answers — Department of Health: Health Services (5 Nov 2024)
Stephen Donnelly: As this is a service matter, it has been referred to the Health Service Executive for attention and direct reply to the Deputy.
- Written Answers — Department of Health: Health Services (5 Nov 2024)
Stephen Donnelly: As this is a service matter, it has been referred to the Health Service Executive for attention and direct reply to the Deputy.
- Written Answers — Department of Health: Health Services (5 Nov 2024)
Stephen Donnelly: As this is a service matter, it has been referred to the Health Service Executive for attention and direct reply to the Deputy.
- Written Answers — Department of Health: Disease Management (5 Nov 2024)
Stephen Donnelly: I propose to take Questions Nos. 1126 and 1127 together. The National Rare Disease Steering Group was established in December 2023 and is chaired by Prof. Cecily Kelleher. The Steering Group have been tasked with developing a new Rare Disease Strategy for Ireland that sets out the vision for rare disease services in Ireland and the actions required to achieve this. The Steering Group is...
- Written Answers — Department of Health: Departmental Funding (5 Nov 2024)
Stephen Donnelly: As the Deputy will be aware, I recently announced details of the €1.5 million allocation for the development of rare disease services as part of Budget 2025. This funding seeks to address the immediate gaps within rare disease services in Ireland and ensure that our National Rare Disease Office and European Reference Networks are better resourced to carry out their functions and to...
- Written Answers — Department of Health: Departmental Funding (5 Nov 2024)
Stephen Donnelly: A record of over €3 billion, nearly €1 in every 8 of public funding spent on health, was spent last year on medicines. This is an unprecedented level of investment in supporting patients through the availability of the latest and wide range of medicines. The State has made an additional €128 million available since 2020 which has seen 187 new medicines or new uses for...
- Written Answers — Department of Health: Health Strategies (5 Nov 2024)
Stephen Donnelly: The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. The HSE is committed to providing access to as many medicines as possible, in as timely a fashion as possible. The HSE robustly assesses applications for...